SlideShare a Scribd company logo
1 of 16
z
NOIDA INSTITUTE OF ENGINEERING AND TECHNOLOGY
Pharmacological Screening of Anti Diarrheal Agent
Presented by- Submitted to-
Arbaz Khan Dr. Saumya Das
M.Pharm (Pharmacology) 1st sem Associate Professor
z
INTRODUCTION
 DIARRHEA
Diarrhea is characterized by increased frequency of bowel movement, wet stool and abdominal pain.
1.Acute diarrhea
 Self limiting
 Last from 3 days to 2 weeks
 Sudden onset in a previously healthy person
 Resolve without sequelae
2. Chronic diarrhea
 Last for more than 3 weeks
 Associated with recurring passage of diarrheal stools, fever, loss of appetite, nausea, vomiting, weight
loss, and chronic weakness.
z
CAUSES OF DIARRHEA
Acute Diarrhea Chronic Diarrhea
Bacterial Tumors
Viral Diabetes
Drug Induced Addison’s disease
Protozoal Hyperthyrodism
z
ANTIDIARRHEALS
 Mechanism of Action
 Adsorbents
 Coat the walls of the GI tract
 Bind to the causative bacteria or toxin, which is then eliminated through stool
Examples: bismuth subsalicylate, kaolin-pectin, activated charcoal, etc
 Anticholinergics
 Decrease intestinal muscle tone and peristalsis of GI tract
 Result: slowing the movement of fecal matter through the GI tract
 Examples: belladona alkaloids, atropine, etc
z
 Intestinal flora modifiers (IFM)
 Bacterial cultures of Lactobacillus organisms work by:
 Supplying missing bacteria to the GI tract
 Suppressing the growth of diarrhea-causing bacterial
 Example: L. acidophilus.
 Opiates
 Decrease bowel motility and relieve rectal spasms
 Decrease transit time through the bowel, allowing more time for water and electrolytes
to be absorbed.
 Examples: opium tincture, codeine, loperamide, etc
z
Screening Model
In vivo model
 Castor oil-induced diarrhea
 Gastrointestinal motility test
 Castor oil-induced enterpooling
 Magnesium sulfate-induced diarrhea
z
CASTOR OIL-INDUCED DIARRHOEA
 Rats were fasted for 18hrs and divided into five groups of six animals per group.
 Castor oil at a dose of 1 ml/ animals orally, was given to all groups of animals for the induction of diarrhea.
 Thirty minutes after castor oil administration, the first group (control group) received vehicle (0.5% v/v
Tween 80 in distilled water)
 While the second, third and fourth groups were given petroleum ether extract at doses of 25, 50 and 100
mg/kg body weight respectively by oral route.
 The fifth group received the reference drug, diphenoxylate (50mg/kg body weight)
 Animals of all groups were placed separately in individual cages lined with filter paper.
 The filter papers were changed every hour and the severity of diarrhea was assessed hourly for six hours.
 The total number of faeces excreted and the total weight of faeces were recorded within a period of six
hour and compared with the control group.
 The total number of diarrheal facces of the control group was considered 100%
 The results were expressed as percentage of inhibition of diarrhea
z
GASTROINTESTINAL MOTILITY TEST
 This experiment was done by using charcoal meal as a diet.The rats were divided into five
groups of six animals each and fasted for eighteen hours before the experiment.
 The first group (the control group) was orally administered the vehicle (0.5% Tween 80 in
distilled water).
 The second third and fourth groups orally received petroleum ether extract at doses of 25,
50 and 100 mg/kg body weight respectively.
 The fifth group received the standard drug, atropine sulfate (0.1 mg/kg body weight
intraperitoneal)
 Thirty minutes later each animal was given 1 ml of charcoal meal (10% activated charcoal
in 5% gum acacia) orally.
 Each animal was sacrificed thirty minutes after administration of charcoal meal.
 The distance covered by the charcoal meal in the intestine was expressed as a
percentage of the total distance traveled from the pylorus to the cecum.
z
CASTOR OIL INDUCED ENTEROPOOLING
 Intraluminal fluid accumulation was determined by the method of Boominathan et al. 2005
 Over night fasted rats were divided into five groups of six animals each.
 Group 1 which received normal saline (2ml/kg intraperitonial) served as the control group.
 Group 2 received atropine (3 mg/kg intraperitoneal) and groups. 3, 4 and 5 received extract of
25, 50 and 100mg/kg intraperitoneal, respectively, one hour before the oral administration of
castor oil (1ml).
 Two hours later, the rats were sacrificed.
 The small intestine was removed after trying the ends with threads and weighed.
 The intestinal content was collected by milking into a graduated cylinder and their volume was
measured.
 The intestine was reweighed and the difference between the full and empty was calculated.
z
MAGNESIUM SULFATE-INDUCED DIARRHEA
 Animals are fasted for a period of 12-18 hours and are grouped into control, reference,
and test groups.
 After I hour of treatment, animals are dosed with magnesium sulfate.
 Then they are housed in their separate cages for 4 hours.
 Using this technique, magnesium sulfate was administered 30 minutes before treatment.
 This is a curative approach unlike the preventive approach where the test substance is
administered before induction of diarrhea.
z
EVALUATION
 With anti-diarrheal agents dose-response curve are obtained for decrease of
hyper-secretion (stool weight) and increase of the diarrhea-free period are
obtained.
 Inhibitors of prostaglandin biosynthesis increase the diarrhea free period but do
not affect early diarrheal secretion
z
In Vitro Model
 Gastrointestinal Motility
 Adult C57 mice (8–10 weeks) were starved for 24 h and then divided into
four groups of four mice each, administered respectively with saline, Eact,
plumbagin, and Eact plus plumbagin.
 Fifteen minutes later, mice were orally administered a charcoal meal (0.2 ml
of 10% activated charcoal suspended in 5% gum acacia) over a 30-min
period.
 Afterward, mice were sacrificed, and the small intestines were isolated. The
peristaltic index was calculated as the percentage of distance traveled by the
charcoal relative to the total length of the small intestine.
z
Canine Slow Transit Constipation Model:
 Baseline data were measured in 8 beagle dogs, randomly dividing these animals
into the control group and model group.
 A diet of canned meat and a mixture of compound diphenoxylate and alosetron
hydrochloride for 5 weeks were provided to the dogs in the model group.
 With no special intervention,dogs in the control group were provided an ordinary
diet.
 The tool frequency and consistency were noted and recorded daily, and every
week, the gastrointestinal transit time (GITT) was evaluated
z
 All animals underwent midline laparotomy, and the colonic tissues were
taken from the rectosigmoid colon,
 then investigated by light microscopy, electron microscopy, and immune-
histochemistry to assess changes in the protein gene product 9.5.
z REFERENCE
 Tripathi KD (ed.). Essentials of Medical Pharmacology (6th ed.). New Delhi: Jaypee
Publications.
 Bimlesh K, Kalyani D, Prashant T, Manoj S, Diwakar G. Evaluation of antidiarrheal
effect of aqueous and ethanolic extracts of fruit pulp of Terminalia belerica in rats. Int J
Drug Dev Res 2010.
 www.slideshare.com
 https://www.researchgate.net/publication/32604740
z
 THANKYOU

More Related Content

What's hot

Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsHimikaRathi
 
Screening of hepatoprotective drugs
Screening of hepatoprotective drugsScreening of hepatoprotective drugs
Screening of hepatoprotective drugsDipanjaliKamthe
 
Screening models on aphrodisiac agents
Screening models on aphrodisiac agentsScreening models on aphrodisiac agents
Screening models on aphrodisiac agentsJaineel Dharod
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agentSONALPANDE5
 
Screening of anti emetics drug
Screening of anti emetics drugScreening of anti emetics drug
Screening of anti emetics drugRajeshwar Yadav
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugsDHINESHKUMAR V
 
Screening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwakerScreening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwakerShivam Diwaker
 
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docxSCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docxTUSHARUNDHAD3
 
Screening of anti anginal and anti-allergic drugs -autosaved-
Screening of anti anginal and anti-allergic drugs -autosaved-Screening of anti anginal and anti-allergic drugs -autosaved-
Screening of anti anginal and anti-allergic drugs -autosaved-Gurubarath1
 
Screening models for immunomodulator
Screening models for immunomodulatorScreening models for immunomodulator
Screening models for immunomodulatorMr. MOHD FAHAD
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activitySravanthi Shetty
 
Preclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activityPreclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activityShrutiGautam18
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugsdrarunsingh4
 
Anti epileptic screening model
Anti epileptic screening modelAnti epileptic screening model
Anti epileptic screening modelKhushbooThakur15
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methodsShobhiniChandel
 
IMMUNOASSAY OF DIGOXIN
IMMUNOASSAY OF DIGOXINIMMUNOASSAY OF DIGOXIN
IMMUNOASSAY OF DIGOXINJayhindBharti
 
Screening Models of Antidepressants Drugs
Screening Models of Antidepressants DrugsScreening Models of Antidepressants Drugs
Screening Models of Antidepressants DrugsKomalSingh301
 
screening of antiulcer agents
screening  of antiulcer agentsscreening  of antiulcer agents
screening of antiulcer agentsUttara Joshi
 

What's hot (20)

Anti emetic models
Anti emetic modelsAnti emetic models
Anti emetic models
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
 
Screening of hepatoprotective drugs
Screening of hepatoprotective drugsScreening of hepatoprotective drugs
Screening of hepatoprotective drugs
 
Screening models on aphrodisiac agents
Screening models on aphrodisiac agentsScreening models on aphrodisiac agents
Screening models on aphrodisiac agents
 
Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
 
Screening of anti emetics drug
Screening of anti emetics drugScreening of anti emetics drug
Screening of anti emetics drug
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening Models of Anti-Atherosclerosis
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugs
 
Screening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwakerScreening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwaker
 
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docxSCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
SCREENING MODELS OF ANTIDYSLIPIDEMIC AGENT.docx
 
Screening of anti anginal and anti-allergic drugs -autosaved-
Screening of anti anginal and anti-allergic drugs -autosaved-Screening of anti anginal and anti-allergic drugs -autosaved-
Screening of anti anginal and anti-allergic drugs -autosaved-
 
Screening models for immunomodulator
Screening models for immunomodulatorScreening models for immunomodulator
Screening models for immunomodulator
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
 
Preclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activityPreclinical screening of new substance for pharmacological activity
Preclinical screening of new substance for pharmacological activity
 
Screening of antipyretic drugs
Screening of antipyretic drugsScreening of antipyretic drugs
Screening of antipyretic drugs
 
Anti epileptic screening model
Anti epileptic screening modelAnti epileptic screening model
Anti epileptic screening model
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
 
IMMUNOASSAY OF DIGOXIN
IMMUNOASSAY OF DIGOXINIMMUNOASSAY OF DIGOXIN
IMMUNOASSAY OF DIGOXIN
 
Screening Models of Antidepressants Drugs
Screening Models of Antidepressants DrugsScreening Models of Antidepressants Drugs
Screening Models of Antidepressants Drugs
 
screening of antiulcer agents
screening  of antiulcer agentsscreening  of antiulcer agents
screening of antiulcer agents
 

Similar to Pharmacological screening of anti diarrheal agent

Anti ulcer screening
Anti ulcer screeningAnti ulcer screening
Anti ulcer screeningPavana K A
 
SAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptxSAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptxRushikeshTidake
 
Screening method of peptic ulcer disease.pptx
Screening method of peptic ulcer disease.pptxScreening method of peptic ulcer disease.pptx
Screening method of peptic ulcer disease.pptxTUSHARUNDHAD3
 
STUDY ON ANTI ULCER AND ANTI INFLAMMATORY EFFECTS OF Vilvathi Lehiyam
STUDY ON ANTI ULCER AND ANTI INFLAMMATORY EFFECTS OF Vilvathi LehiyamSTUDY ON ANTI ULCER AND ANTI INFLAMMATORY EFFECTS OF Vilvathi Lehiyam
STUDY ON ANTI ULCER AND ANTI INFLAMMATORY EFFECTS OF Vilvathi LehiyamJing Zang
 
screening of antiulcer agent
screening of antiulcer agentscreening of antiulcer agent
screening of antiulcer agentchetan jain
 
Hepatoprotective drugs, a detailed discussion..ppt
Hepatoprotective drugs, a detailed discussion..pptHepatoprotective drugs, a detailed discussion..ppt
Hepatoprotective drugs, a detailed discussion..pptJyotshnaDevi4
 
Screening methods for Anti Ulcer Drugs
Screening methods for Anti Ulcer DrugsScreening methods for Anti Ulcer Drugs
Screening methods for Anti Ulcer DrugsFoziyaKhan
 
SCREENING METHODS of antiulcer drugs.pptx
SCREENING METHODS of antiulcer drugs.pptxSCREENING METHODS of antiulcer drugs.pptx
SCREENING METHODS of antiulcer drugs.pptxShivangiVaish5
 
2. To study effect of drugs on gastrointestinal motility Experiment .pptx
2. To study effect of drugs on gastrointestinal motility Experiment  .pptx2. To study effect of drugs on gastrointestinal motility Experiment  .pptx
2. To study effect of drugs on gastrointestinal motility Experiment .pptxsampharma12584
 
Cryotherapy - Use in cases of acute laminitis
Cryotherapy - Use in cases of acute laminitisCryotherapy - Use in cases of acute laminitis
Cryotherapy - Use in cases of acute laminitisLouise Best
 
Screening of anti ulcer drugs - Dr Divya Krishnan
Screening of anti ulcer drugs - Dr Divya KrishnanScreening of anti ulcer drugs - Dr Divya Krishnan
Screening of anti ulcer drugs - Dr Divya KrishnanDivya Krishnan
 
Effect Of Siddha Drug (Kantha Chendooram) On
Effect Of Siddha Drug (Kantha Chendooram) OnEffect Of Siddha Drug (Kantha Chendooram) On
Effect Of Siddha Drug (Kantha Chendooram) Onaraghuram
 

Similar to Pharmacological screening of anti diarrheal agent (20)

BHAWANA SHARMA ppt ptsm 1.pptx
BHAWANA SHARMA ppt ptsm 1.pptxBHAWANA SHARMA ppt ptsm 1.pptx
BHAWANA SHARMA ppt ptsm 1.pptx
 
SCREENING OF METHOD EMETIC ANTIEMETICS
SCREENING OF METHOD  EMETIC  ANTIEMETICSSCREENING OF METHOD  EMETIC  ANTIEMETICS
SCREENING OF METHOD EMETIC ANTIEMETICS
 
Anti ulcer screening
Anti ulcer screeningAnti ulcer screening
Anti ulcer screening
 
SAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptxSAFETY PHARMACOLOGY STUDIES final .pptx
SAFETY PHARMACOLOGY STUDIES final .pptx
 
Dr bushra antiulcer screening
Dr bushra antiulcer screeningDr bushra antiulcer screening
Dr bushra antiulcer screening
 
Screening method of peptic ulcer disease.pptx
Screening method of peptic ulcer disease.pptxScreening method of peptic ulcer disease.pptx
Screening method of peptic ulcer disease.pptx
 
STUDY ON ANTI ULCER AND ANTI INFLAMMATORY EFFECTS OF Vilvathi Lehiyam
STUDY ON ANTI ULCER AND ANTI INFLAMMATORY EFFECTS OF Vilvathi LehiyamSTUDY ON ANTI ULCER AND ANTI INFLAMMATORY EFFECTS OF Vilvathi Lehiyam
STUDY ON ANTI ULCER AND ANTI INFLAMMATORY EFFECTS OF Vilvathi Lehiyam
 
screening of antiulcer agent
screening of antiulcer agentscreening of antiulcer agent
screening of antiulcer agent
 
ali f .pptx
ali f .pptxali f .pptx
ali f .pptx
 
Hepatoprotective drugs, a detailed discussion..ppt
Hepatoprotective drugs, a detailed discussion..pptHepatoprotective drugs, a detailed discussion..ppt
Hepatoprotective drugs, a detailed discussion..ppt
 
Screening methods for Anti Ulcer Drugs
Screening methods for Anti Ulcer DrugsScreening methods for Anti Ulcer Drugs
Screening methods for Anti Ulcer Drugs
 
Anti ulcer
Anti ulcerAnti ulcer
Anti ulcer
 
SCREENING METHODS of antiulcer drugs.pptx
SCREENING METHODS of antiulcer drugs.pptxSCREENING METHODS of antiulcer drugs.pptx
SCREENING METHODS of antiulcer drugs.pptx
 
Screening of anti-emetic drugs
Screening of anti-emetic drugsScreening of anti-emetic drugs
Screening of anti-emetic drugs
 
2. To study effect of drugs on gastrointestinal motility Experiment .pptx
2. To study effect of drugs on gastrointestinal motility Experiment  .pptx2. To study effect of drugs on gastrointestinal motility Experiment  .pptx
2. To study effect of drugs on gastrointestinal motility Experiment .pptx
 
Cryotherapy - Use in cases of acute laminitis
Cryotherapy - Use in cases of acute laminitisCryotherapy - Use in cases of acute laminitis
Cryotherapy - Use in cases of acute laminitis
 
Screening of anti ulcer drugs - Dr Divya Krishnan
Screening of anti ulcer drugs - Dr Divya KrishnanScreening of anti ulcer drugs - Dr Divya Krishnan
Screening of anti ulcer drugs - Dr Divya Krishnan
 
Effect Of Siddha Drug (Kantha Chendooram) On
Effect Of Siddha Drug (Kantha Chendooram) OnEffect Of Siddha Drug (Kantha Chendooram) On
Effect Of Siddha Drug (Kantha Chendooram) On
 
SUB ACUTE ORAL TOXICITY
SUB ACUTE ORAL TOXICITYSUB ACUTE ORAL TOXICITY
SUB ACUTE ORAL TOXICITY
 
PCOG-J 2011
PCOG-J 2011PCOG-J 2011
PCOG-J 2011
 

Recently uploaded

Green chemistry and Sustainable development.pptx
Green chemistry  and Sustainable development.pptxGreen chemistry  and Sustainable development.pptx
Green chemistry and Sustainable development.pptxRajatChauhan518211
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPirithiRaju
 
Nanoparticles synthesis and characterization​ ​
Nanoparticles synthesis and characterization​  ​Nanoparticles synthesis and characterization​  ​
Nanoparticles synthesis and characterization​ ​kaibalyasahoo82800
 
Botany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdfBotany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdfSumit Kumar yadav
 
Pulmonary drug delivery system M.pharm -2nd sem P'ceutics
Pulmonary drug delivery system M.pharm -2nd sem P'ceuticsPulmonary drug delivery system M.pharm -2nd sem P'ceutics
Pulmonary drug delivery system M.pharm -2nd sem P'ceuticssakshisoni2385
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)Areesha Ahmad
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisDiwakar Mishra
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSarthak Sekhar Mondal
 
VIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PVIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PPRINCE C P
 
Zoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfZoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfSumit Kumar yadav
 
fundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomologyfundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomologyDrAnita Sharma
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSSLeenakshiTyagi
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡anilsa9823
 
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.Nitya salvi
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...Sérgio Sacani
 

Recently uploaded (20)

Green chemistry and Sustainable development.pptx
Green chemistry  and Sustainable development.pptxGreen chemistry  and Sustainable development.pptx
Green chemistry and Sustainable development.pptx
 
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdfPests of cotton_Sucking_Pests_Dr.UPR.pdf
Pests of cotton_Sucking_Pests_Dr.UPR.pdf
 
Nanoparticles synthesis and characterization​ ​
Nanoparticles synthesis and characterization​  ​Nanoparticles synthesis and characterization​  ​
Nanoparticles synthesis and characterization​ ​
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
Botany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdfBotany 4th semester series (krishna).pdf
Botany 4th semester series (krishna).pdf
 
Pulmonary drug delivery system M.pharm -2nd sem P'ceutics
Pulmonary drug delivery system M.pharm -2nd sem P'ceuticsPulmonary drug delivery system M.pharm -2nd sem P'ceutics
Pulmonary drug delivery system M.pharm -2nd sem P'ceutics
 
GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)GBSN - Microbiology (Unit 2)
GBSN - Microbiology (Unit 2)
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
 
VIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C PVIRUSES structure and classification ppt by Dr.Prince C P
VIRUSES structure and classification ppt by Dr.Prince C P
 
Zoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfZoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdf
 
fundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomologyfundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomology
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSS
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
 
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
 

Pharmacological screening of anti diarrheal agent

  • 1. z NOIDA INSTITUTE OF ENGINEERING AND TECHNOLOGY Pharmacological Screening of Anti Diarrheal Agent Presented by- Submitted to- Arbaz Khan Dr. Saumya Das M.Pharm (Pharmacology) 1st sem Associate Professor
  • 2. z INTRODUCTION  DIARRHEA Diarrhea is characterized by increased frequency of bowel movement, wet stool and abdominal pain. 1.Acute diarrhea  Self limiting  Last from 3 days to 2 weeks  Sudden onset in a previously healthy person  Resolve without sequelae 2. Chronic diarrhea  Last for more than 3 weeks  Associated with recurring passage of diarrheal stools, fever, loss of appetite, nausea, vomiting, weight loss, and chronic weakness.
  • 3. z CAUSES OF DIARRHEA Acute Diarrhea Chronic Diarrhea Bacterial Tumors Viral Diabetes Drug Induced Addison’s disease Protozoal Hyperthyrodism
  • 4. z ANTIDIARRHEALS  Mechanism of Action  Adsorbents  Coat the walls of the GI tract  Bind to the causative bacteria or toxin, which is then eliminated through stool Examples: bismuth subsalicylate, kaolin-pectin, activated charcoal, etc  Anticholinergics  Decrease intestinal muscle tone and peristalsis of GI tract  Result: slowing the movement of fecal matter through the GI tract  Examples: belladona alkaloids, atropine, etc
  • 5. z  Intestinal flora modifiers (IFM)  Bacterial cultures of Lactobacillus organisms work by:  Supplying missing bacteria to the GI tract  Suppressing the growth of diarrhea-causing bacterial  Example: L. acidophilus.  Opiates  Decrease bowel motility and relieve rectal spasms  Decrease transit time through the bowel, allowing more time for water and electrolytes to be absorbed.  Examples: opium tincture, codeine, loperamide, etc
  • 6. z Screening Model In vivo model  Castor oil-induced diarrhea  Gastrointestinal motility test  Castor oil-induced enterpooling  Magnesium sulfate-induced diarrhea
  • 7. z CASTOR OIL-INDUCED DIARRHOEA  Rats were fasted for 18hrs and divided into five groups of six animals per group.  Castor oil at a dose of 1 ml/ animals orally, was given to all groups of animals for the induction of diarrhea.  Thirty minutes after castor oil administration, the first group (control group) received vehicle (0.5% v/v Tween 80 in distilled water)  While the second, third and fourth groups were given petroleum ether extract at doses of 25, 50 and 100 mg/kg body weight respectively by oral route.  The fifth group received the reference drug, diphenoxylate (50mg/kg body weight)  Animals of all groups were placed separately in individual cages lined with filter paper.  The filter papers were changed every hour and the severity of diarrhea was assessed hourly for six hours.  The total number of faeces excreted and the total weight of faeces were recorded within a period of six hour and compared with the control group.  The total number of diarrheal facces of the control group was considered 100%  The results were expressed as percentage of inhibition of diarrhea
  • 8. z GASTROINTESTINAL MOTILITY TEST  This experiment was done by using charcoal meal as a diet.The rats were divided into five groups of six animals each and fasted for eighteen hours before the experiment.  The first group (the control group) was orally administered the vehicle (0.5% Tween 80 in distilled water).  The second third and fourth groups orally received petroleum ether extract at doses of 25, 50 and 100 mg/kg body weight respectively.  The fifth group received the standard drug, atropine sulfate (0.1 mg/kg body weight intraperitoneal)  Thirty minutes later each animal was given 1 ml of charcoal meal (10% activated charcoal in 5% gum acacia) orally.  Each animal was sacrificed thirty minutes after administration of charcoal meal.  The distance covered by the charcoal meal in the intestine was expressed as a percentage of the total distance traveled from the pylorus to the cecum.
  • 9. z CASTOR OIL INDUCED ENTEROPOOLING  Intraluminal fluid accumulation was determined by the method of Boominathan et al. 2005  Over night fasted rats were divided into five groups of six animals each.  Group 1 which received normal saline (2ml/kg intraperitonial) served as the control group.  Group 2 received atropine (3 mg/kg intraperitoneal) and groups. 3, 4 and 5 received extract of 25, 50 and 100mg/kg intraperitoneal, respectively, one hour before the oral administration of castor oil (1ml).  Two hours later, the rats were sacrificed.  The small intestine was removed after trying the ends with threads and weighed.  The intestinal content was collected by milking into a graduated cylinder and their volume was measured.  The intestine was reweighed and the difference between the full and empty was calculated.
  • 10. z MAGNESIUM SULFATE-INDUCED DIARRHEA  Animals are fasted for a period of 12-18 hours and are grouped into control, reference, and test groups.  After I hour of treatment, animals are dosed with magnesium sulfate.  Then they are housed in their separate cages for 4 hours.  Using this technique, magnesium sulfate was administered 30 minutes before treatment.  This is a curative approach unlike the preventive approach where the test substance is administered before induction of diarrhea.
  • 11. z EVALUATION  With anti-diarrheal agents dose-response curve are obtained for decrease of hyper-secretion (stool weight) and increase of the diarrhea-free period are obtained.  Inhibitors of prostaglandin biosynthesis increase the diarrhea free period but do not affect early diarrheal secretion
  • 12. z In Vitro Model  Gastrointestinal Motility  Adult C57 mice (8–10 weeks) were starved for 24 h and then divided into four groups of four mice each, administered respectively with saline, Eact, plumbagin, and Eact plus plumbagin.  Fifteen minutes later, mice were orally administered a charcoal meal (0.2 ml of 10% activated charcoal suspended in 5% gum acacia) over a 30-min period.  Afterward, mice were sacrificed, and the small intestines were isolated. The peristaltic index was calculated as the percentage of distance traveled by the charcoal relative to the total length of the small intestine.
  • 13. z Canine Slow Transit Constipation Model:  Baseline data were measured in 8 beagle dogs, randomly dividing these animals into the control group and model group.  A diet of canned meat and a mixture of compound diphenoxylate and alosetron hydrochloride for 5 weeks were provided to the dogs in the model group.  With no special intervention,dogs in the control group were provided an ordinary diet.  The tool frequency and consistency were noted and recorded daily, and every week, the gastrointestinal transit time (GITT) was evaluated
  • 14. z  All animals underwent midline laparotomy, and the colonic tissues were taken from the rectosigmoid colon,  then investigated by light microscopy, electron microscopy, and immune- histochemistry to assess changes in the protein gene product 9.5.
  • 15. z REFERENCE  Tripathi KD (ed.). Essentials of Medical Pharmacology (6th ed.). New Delhi: Jaypee Publications.  Bimlesh K, Kalyani D, Prashant T, Manoj S, Diwakar G. Evaluation of antidiarrheal effect of aqueous and ethanolic extracts of fruit pulp of Terminalia belerica in rats. Int J Drug Dev Res 2010.  www.slideshare.com  https://www.researchgate.net/publication/32604740